Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is EuroEyes International Eye Clinic Days Payable?
EuroEyes International Eye ClinicHKSE:01846 +2.04%83 Days Payable is 24.42 as of Dec. 2025, which is 10% below its 10-year median of 27.23. GuruFocus rates HKSE:01846 with a GF Score™ of 83/100 and a GF Value™ of HK$5.56 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 605 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks worse than 79.5% on this metric.
The historical rank and industry rank for EuroEyes International Eye Clinic's Days Payable or its related term are showing as below:
HKSE:01846'
s Days Payable Range Over the Past 10 Years
Min: 20.26 Med: 27.23 Max: 42.39
Current: 23.81
During the past 10 years, EuroEyes International Eye Clinic's highest Days Payable was 42.39. The lowest was 20.26. And the median was 27.23.
HKSE:01846's Days Payable is ranked worse than 79.5% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 57.08
vs HKSE:01846: 23.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic Days Payable Chart
HKSE:01846 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's Days Payable distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's Days Payable falls into.
EuroEyes International Eye Clinic Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic (HKSE:01846) has a Days Payable of 24.42 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on EuroEyes International Eye Clinic and its competitors. This is 10% below median its historical median of 27.23. Over the past decade, EuroEyes International Eye Clinic's Days Payable has ranged from 20.26 to 42.39. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #481 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 79.5%.
Is EuroEyes International Eye Clinic's Days Payable too high?
EuroEyes International Eye Clinic's current Days Payable of 24.42 is 10% below median its 10-year median of 27.23. Over the past 10 years, this metric has ranged from a low of 20.26 to a high of 42.39. The Healthcare Providers & Services industry median Days Payable is 57.08. EuroEyes International Eye Clinic's value of 24.42 is 57.2% below this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #481 out of 605 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, EuroEyes International Eye Clinic has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #481 out of 605 companies for Days Payable. This places EuroEyes International Eye Clinic in the lower half of its industry. The industry median Days Payable is 57.08. EuroEyes International Eye Clinic's value of 24.42 is 57.2% below this benchmark. Historically, EuroEyes International Eye Clinic's own Days Payable has ranged from 20.26 to 42.39 over the past decade. While the company's 10-year median is 27.23 vs. the industry median of 57.08, EuroEyes International Eye Clinic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.08, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current Days Payable of 24.42 is 57.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current Days Payable is 24.42, which is 10% below median its own 10-year median of 27.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.56, compared to a current price of HK$2.50 — trading 55% below its estimated fair value. The current Days Payable is 24.42, which is 10% below median its 10-year median of 27.23 and 57.2% below the Healthcare Providers & Services industry median of 57.08. EuroEyes International Eye Clinic's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current Days Payable is 24.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.50 is trading 55% below its estimated GF Value™ of HK$5.56.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
Days Payable: 24.42 (10% below median its 10-year median of 27.23)
GF Value™: HK$5.56 vs. price of HK$2.50 (55% below fair value)
Industry Position: 57.2% below the Healthcare Providers & Services median (#481 of 605)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
83GF Score
Get the complete analysis for HKSE:01846
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
